Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Amivantamab-vmjw
Trade Name Rybrevant
Synonyms JNJ-61186372
Drug Descriptions

Rybrevant (amivantamab-vmjw) is a bi-specific antibody that targets EGFR and MET, resulting in inhibition of downstream signaling and potentially leading to decreased growth of EGFR and/or MET-expressing tumors (PMID: 27216193, PMID: 32414908). Rybrevant (amivantamab-vmjw) is FDA approved for use in patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR exon 20 insertion mutations, whose disease has progressed on or after platinum-based chemotherapy (FDA.gov).

DrugClasses EGFR Antibody 58 MET Antibody 29
CAS Registry Number 2171511-58-1
NCIT ID C124993

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Amivantamab-vmjw Amivantamab-vmjw 0 10
Amivantamab-vmjw + Bevacizumab + Lazertinib Amivantamab-vmjw Bevacizumab Lazertinib 0 1
Amivantamab-vmjw + Capmatinib Amivantamab-vmjw Capmatinib 0 1
Amivantamab-vmjw + Carboplatin + Lazertinib + Pemetrexed Disodium Amivantamab-vmjw Carboplatin Lazertinib Pemetrexed Disodium 0 3
Amivantamab-vmjw + Carboplatin + Pemetrexed Disodium Amivantamab-vmjw Carboplatin Pemetrexed Disodium 0 4
Amivantamab-vmjw + Cetrelimab Amivantamab-vmjw Cetrelimab 0 1
Amivantamab-vmjw + Dexamethasone + Lazertinib Amivantamab-vmjw Dexamethasone Lazertinib 0 1
Amivantamab-vmjw + Fluorouracil + Irinotecan + Leucovorin Amivantamab-vmjw Fluorouracil Irinotecan Leucovorin 0 1
Amivantamab-vmjw + Fluorouracil + Leucovorin + Oxaliplatin Amivantamab-vmjw Fluorouracil Leucovorin Oxaliplatin 0 1
Amivantamab-vmjw + Lazertinib Amivantamab-vmjw Lazertinib 0 7
Amivantamab-vmjw + Lazertinib + Methotrexate Amivantamab-vmjw Lazertinib Methotrexate 0 1
Amivantamab-vmjw + Lazertinib + Montelukast Amivantamab-vmjw Lazertinib Montelukast 0 1
Amivantamab-vmjw + Lazertinib + rHuPH20 Amivantamab-vmjw Lazertinib rHuPH20 0 1
Amivantamab-vmjw + Osimertinib Amivantamab-vmjw Osimertinib 0 1
Amivantamab-vmjw + Paclitaxel Amivantamab-vmjw Paclitaxel 0 1
Amivantamab-vmjw + Pembrolizumab Amivantamab-vmjw Pembrolizumab 0 1
Amivantamab-vmjw + rHuPH20 Amivantamab-vmjw rHuPH20 0 1
Amivantamab-vmjw + Tepotinib Amivantamab-vmjw Tepotinib 0 1


Additional content available in CKB BOOST